These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 31112124)

  • 41. Prescription Birth Control Access Among U.S. Women at Risk of Unintended Pregnancy.
    Grindlay K; Grossman D
    J Womens Health (Larchmt); 2016 Mar; 25(3):249-54. PubMed ID: 26666711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prescription Drugs-List Price, Net Price, and the Rebate Caught in the Middle.
    Dusetzina SB; Bach PB
    JAMA; 2019 Apr; 321(16):1563-1564. PubMed ID: 30840047
    [No Abstract]   [Full Text] [Related]  

  • 43. Parental preferences for FDA-approved medications prescribed for their children.
    Yoon EY; Clark SJ; Butchart A; Singer D; Davis MM
    Clin Pediatr (Phila); 2011 Mar; 50(3):208-14. PubMed ID: 21098519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
    Hwang TJ; Jain N; Lauffenburger JC; Vokinger KN; Kesselheim AS
    JAMA Intern Med; 2019 Mar; 179(3):374-380. PubMed ID: 30640379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.
    Gudiksen KL; King JS
    J Leg Med; 2019; 39(2):95-120. PubMed ID: 31503534
    [No Abstract]   [Full Text] [Related]  

  • 47. Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia.
    Doshi JA; Li P; Desai S; Marcus SC
    J Med Econ; 2017 Dec; 20(12):1252-1260. PubMed ID: 28792299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association Between Narrow Pharmacy Networks and Medication Adherence.
    Polinski JM; Matlin OS; Sullivan C; Gagnon M; Brennan TA; Shrank WH
    JAMA Intern Med; 2015 Nov; 175(11):1850-3. PubMed ID: 26348504
    [No Abstract]   [Full Text] [Related]  

  • 49. Medicare-approved drug discount cards and renal transplant patients: how much can these cards reduce prescription costs?
    Chisholm MA; Marshall J; Smith KE; Garrett CJ; Turner JC
    Clin Transplant; 2005 Jun; 19(3):357-63. PubMed ID: 15877798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS; Avorn J; Sarpatwari A
    JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Promoting access and reducing expected out-of-pocket prescription drug costs for vulnerable Medicare beneficiaries: a pharmacist-directed model.
    Cutler TW; Stebbins MR; Smith AR; Patel RA; Lipton HL
    Med Care; 2011 Apr; 49(4):343-7. PubMed ID: 21407030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prescription medication borrowing and sharing among women of reproductive age.
    Petersen EE; Rasmussen SA; Daniel KL; Yazdy MM; Honein MA
    J Womens Health (Larchmt); 2008 Sep; 17(7):1073-80. PubMed ID: 18774892
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008.
    Gu Q; Dillon CF; Burt VL
    NCHS Data Brief; 2010 Sep; (42):1-8. PubMed ID: 20854747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of prescription drug costs in the United States and the United Kingdom, Part 1: statins.
    Jick H; Wilson A; Wiggins P; Chamberlin DP
    Pharmacotherapy; 2012 Jan; 32(1):1-6. PubMed ID: 22392823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. More nonelderly Americans face problems affording prescription drugs.
    Felland LE; Reschovsky JD
    Track Rep; 2009 Jan; (22):1-4. PubMed ID: 19320083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is cost-related non-collection of prescriptions associated with a reduction in health? Findings from a large-scale longitudinal study of New Zealand adults.
    Jatrana S; Richardson K; Norris P; Crampton P
    BMJ Open; 2015 Nov; 5(11):e007781. PubMed ID: 26553826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws.
    Dusetzina SB; Huskamp HA; Winn AN; Basch E; Keating NL
    JAMA Oncol; 2018 Jun; 4(6):e173598. PubMed ID: 29121177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prescription medication costs: a study of physician familiarity.
    Ernst ME; Kelly MW; Hoehns JD; Swegle JM; Buys LM; Logemann CD; Ford JK; Kautzman HA; Sorofman BA; Pretorius RW
    Arch Fam Med; 2000; 9(10):1002-7. PubMed ID: 11115199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring the Valley of Savings: Minimizing Part D Costs and Optimizing Drug Therapy Outcomes in Medicare Beneficiaries With Developmental Disability.
    Rogan EL; Ranson CA; Mori TK; Park SK; Lam HM; Legaspi JF; Tran LK; Cameros CJM; Blackburn AN; Lee ST; Valle-Oseguera CS; Pham CN; Woelfel JA; Patel RA
    Intellect Dev Disabil; 2019 Jun; 57(3):234-241. PubMed ID: 31120407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of prescription drug costs in the United States and the United Kingdom, part 2: proton pump inhibitors.
    Jick H; Wilson A; Wiggins P; Chamberlain DP
    Pharmacotherapy; 2012 Jun; 32(6):489-92. PubMed ID: 22511180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.